Back to Rankings

VTRS

ViatrisA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
VTRS vs peer average
77/100
VTRS vs. peer average (A vs. C)
Grade spread
A 2 · B 2 · C 3 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Useful as a mature biotech/pharma cash-generation peer, but the mix is much more innovation-heavy and less generic-driven than Viatris.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
VTRS
Viatris
AMGN
Amgen
Grade
A
C
Momentum
83
36
Value
65
64
Sentiment
48
47
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs AMGN

VTRS / AMGN
Grade Position
Above peers
VTRS vs. peer average (A vs. C)
77/100
Momentum
83
VTRS
Value
65
VTRS
Sentiment
48
VTRS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VTRS
1
AMGN
AMGN
C
60/100
+2
2
GILD
GILD
C
60/100
+2
3
INCY
INCY
B
80/100
+1
4
MRNA
Moderna Inc Common
D
40/100
+3
5
NBIX
Neurocrine Biosciences Inc Common
A
100/100
Even
AMGN is the first peer returned for this comparison set.